These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31114222)

  • 21. Preoperative Systemic Inflammation Score Predicts the Prognosis of Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
    Wang Q; Ye J; Chen Z; Liao X; Wang X; Zhang C; Zheng L; Han P; Wei Q; Bao Y
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337485
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney-Sparing Surgery Has Equivalent Oncological Outcomes to Radical Nephroureterectomy for Ureteral Urothelial Carcinoma.
    Liu K; Zhao H; Ng CF; Teoh JYC; Laguna P; de la Rosette J
    J Endourol; 2024 Sep; 38(9):921-928. PubMed ID: 38756081
    [No Abstract]   [Full Text] [Related]  

  • 23. Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Kim JK; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2017 Jul; 35(7):458.e9-458.e15. PubMed ID: 28347659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer.
    Knittelfelder O; Delago D; Jakse G; Reinisch S; Partl R; Stranzl-Lawatsch H; Renner W; Langsenlehner T
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33228184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.
    Ye J; Zheng L; Chen Z; Wang Q; Liao X; Wang X; Wei Q; Bao Y
    BMC Urol; 2024 Mar; 24(1):62. PubMed ID: 38509518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
    BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
    Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis.
    Su S; Liu L; Li C; Zhang J; Li S
    Front Oncol; 2020; 10():1650. PubMed ID: 33014827
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: Multivariate analysis with propensity score matching.
    Zhao H; Jiao B; Liu K; Luo Z; Ding Z; Lai S; Ren J; Zhang G
    Front Oncol; 2022; 12():984014. PubMed ID: 36059684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.
    Yeh HC; Chang CH; Fang JK; Chen IA; Lin JT; Hong JH; Huang CY; Wang SS; Chen CS; Lo CW; Yu CC; Tseng JS; Lin WR; Jou YC; Cheong IS; Jiang YH; Tsai CY; Hsueh TY; Chen YT; Huang HC; Tsai YC; Lin WY; Wu CC; Lin PH; Lin TW; Wu WJ
    Front Oncol; 2022; 12():872849. PubMed ID: 35719933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.
    Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
    Urol Oncol; 2017 Sep; 35(9):539.e9-539.e16. PubMed ID: 28499734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
    Jan HC; Wu KY; Tai TY; Weng HY; Yang WH; Ou CH; Hu CY
    Cancer Manag Res; 2022; 14():3139-3149. PubMed ID: 36386553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma.
    Jan HC; Yang WH; Ou CH
    Ann Surg Oncol; 2019 Feb; 26(2):669-684. PubMed ID: 30374917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marital status independently predicts survival of patients with upper urinary tract urothelial carcinoma: A population-based study.
    Li K; Wang F; Wang J; Fan C; Sun J
    J Cancer Res Ther; 2021 Dec; 17(7):1709-1717. PubMed ID: 35381743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.
    Ke HL; Li CC; Lee HY; Tu HP; Wei YC; Yeh HC; Wu WJ; Li WM
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
    Tan P; Shi M; Chen J; Xu H; Xie N; Xu H; Jiang Y; Ai JZ; Liu LR; Yang L; Wei Q
    Asian J Androl; 2019; 21(2):163-169. PubMed ID: 30416134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.
    Murakami Y; Matsumoto K; Ikeda M; Utsunomiya T; Hirayama T; Koguchi D; Matsuda D; Okuno N; Taoka Y; Irie A; Iwamura M
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):310-317. PubMed ID: 29356359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.